Target intelligence / Profile preview

Potassium voltage-gated channel subfamily C member 1 (Kv3.1) Potassium voltage-gated channel subfamily C member 2 (Kv3.2) (Kv3.1 (KCNC1 gene) Kv3.2 (KCNC2 gene))

Target
Kv3.1 (KCNC1 gene) Kv3.2 (KCNC2 gene)
Molecular classification
Ion channel, Voltage-gated potassium channel, Tetrameric membrane protein
01

Overview

Kv3.1 and Kv3.2 potassium channels are members of the Kv3 subfamily of voltage-gated ion channels distinguished by their ability to activate and deactivate extremely rapidly at high voltage thresholds, enabling neurons to fire at very high frequencies[1][2][3][7][8]. Each channel is a tetramer, with each subunit containing six transmembrane segments (S1–S6), where S1–S6 form the voltage-sensing domain and S5–S6 create the potassium-selective pore[1][2][6]. The S4 segment carries positively charged residues that detect and respond to changes in membrane potential, triggering channel opening[1][2][6]. Kv3.1 and Kv3.2 are highly expressed in central nervous system regions that require rapid signaling, such as auditory pathways and fast-spiking interneurons[5][7]. They are critical for precise action potential repolarization, synaptic timing, and neurotransmitter release. Disruption due to mutation or dysfunction is linked to diverse neurological diseases, including epilepsy and neurodegenerative disorders[2][6]. These channels are active drug targets, and selective modulators have been structurally characterized to refine their therapeutic potential[1][4].

Other names
Kv3.1Kv3.2KCNC1 (Kv3.1 gene symbol)KCNC2 (Kv3.2 gene symbol)Voltage-gated potassium channel Kv3.1/Kv3.2Kv3 family (sometimes used collectively for Kv3.1–Kv3.4)
02

Mechanism of action

Positive allosteric modulation resulting in stabilized open state of the channel, enhancing fast activation and deactivation Small molecules binding to extracellular turret and voltage-sensing domains to increase potassium conductance and neuronal repolarization Blockers/antagonists may reduce current, impairing fast neuronal firing

03

Biological functions

Rapid repolarization of action potentialsSustained high-frequency neuronal firingPrecise timing of electrical signaling in fast-spiking neuronsNeurotransmitter release modulationAxonal targeting and trafficking
04

Disease associations

Neurodegenerative diseaseEpilepsy (channelopathies)Psychiatric disorders (altered neuronal excitability)Auditory processing deficitsOther neurological disorders
05

Safety considerations

Potential for altered neuronal excitability leading to seizures or neurodegeneration if overactivated or blockedOff-target effects in non-neuronal tissues expressing Kv channelsImpaired sensory processing or motor control with excessive modulation
06

Interacting drugs

AUT5 (selective positive allosteric modulator)

2 more in the full profile.

07

Biomarkers

Genetic variants/mutations in *KCNC1* or *KCNC2* identified in channelopathies (e.g. epilepsy)Neuronal subtypes expressing high Kv3.1/3.2 levels in CNSSpecific clinically validated biomarkers for patient selection are still limited.

Beyond the preview

Go deeper on Potassium voltage-gated channel subfamily C member 1 (Kv3.1) Potassium voltage-gated channel subfamily C member 2 (Kv3.2) (Kv3.1 (KCNC1 gene) Kv3.2 (KCNC2 gene)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium voltage-gated channel subfamily C member 1 (Kv3.1) Potassium voltage-gated channel subfamily C member 2 (Kv3.2) (Kv3.1 (KCNC1 gene) Kv3.2 (KCNC2 gene)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call